G
Guardant Health, Inc. (GH)
NMS – Real Time Price. Currency in USD
149.22
+6.28 (4.39%)
At close: Jun 26, 2026, 4:00 PM EDT
151.00
+1.78 (1.19%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
149.22
+6.28 (4.39%)
At close: Jun 26, 2026, 4:00 PM EDT
151.00
+1.78 (1.19%)
After-hours: Jun 26, 2026, 7:44 PM EDT
No Data
There are no news for this stock.
Total debt $1.7B significantly exceeds cash reserves ($989.3M), raising financial stability concerns
Total current assets $1.4B exceed Total current liabilities $292.1M, highlighting excellent liquidity
Debt-to-equity ratio (-9.4) is well below the industry average (-0.1), showcasing prudent financial management
Interest coverage ratio (-90.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$71.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.68 | 2.46 | 10 | |
| Quick ratio | 4.39 | 2.06 | 10 | |
| Debt to Equity | N/A | -0.13 | 1.0 | |
| Debt to Assets | 0.89 | 1.87 | 2.0 | |
| Interest coverage | -90.09 | 4.31 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 450M | 564M | 739M | 982M | 1.08B |
| Gross Profit | 292M | 337M | 449M | 633M | 701M |
| Operating Income | -535M | -563M | -444M | -436M | -447M |
| Net Income | -655M | -479M | -436M | -416M | -433M |
| EBITDA | -499M | -520M | -401M | -397M | -408M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 35.28 | 6.35 | 7.5 |
| Next quarter | 27.72 | 11.39 | 8.5 |
| Current year | 33.82 | 12.4 | 8.5 |
| Next year | 29.45 | 31.95 | 10 |
| Weighted average score | 8.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 7.25 | 12.78 | 15 | -70.04 | 5.5 |
| Y/Y | 48.26 | -17.77 | -10.38 | 10.07 | 4.8 |
| 3y average | 29.79 | 13.45 | 18.93 | 15.45 | 9.0 |
| 5y average | 28 | -16.16 | -11.45 | -18.51 | 3.3 |
| Weighted average score | 5.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 6.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | Medium | 6.0 |
| Network effect | Narrow | 4.0 |
| Economies of scale | Medium | 6.0 |
| Weighted average score | 5.8 | |